1st Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$460,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs; drug pricing; Alzheimers Screening and Prevention Act (ASAP) (HR 6130, S 3267); Concentrating on High-value Alzheimers Needs to Get to an End Act (CHANGE) (HR 4752. S 2379).

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4752 (119th), H.R. 6130 (119th)

Taxation/Internal Revenue Code TAX

Issues related to tax reform; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (119th)

Trade (domestic/foreign) TRD

Issues related to supply chain manufacturing and tariffs; Section 232 tariff investigation on branded pharmaceuticals.

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Issues related to pharmaceutical Intellectual Property (IP).

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Manufacturing MAN

Issues related to pharmaceutical manufacturing.

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act; PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

LobbyistCovered position, as disclosed
ELIZABETH BROOKS —
TRICIA BROOKS —
AMANDA MAJOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 891 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.